Journal article · 2018 · Open access

Core Symposium

European Psychiatry, 48(S1), S4–S10 · Published 1 March 2018 · DOI 10.1016/j.eurpsy.2017.12.017

Open PDFView at the publisherCite this paper

In brief

“Core Symposium” is a 2018 journal article, published in European Psychiatry. OpenAlex counts 0 citations as of 20 November 2026. It is open access: the full text is free to read at European Psychiatry.

Citations
0

Abstract

Negative symptoms can be observed in a variety of neuropsychiatric disorders and are not specific to a diagnostic category.The dimensional approach aims at developing specific treatments for negative symptoms independent of categorical diagnoses.Although there is no clear evidence for transdiagnostic treatments so far, this approach has stimulated the discussion on potential target mechanisms.Here we provide a selective review of pharmacological and psychosocial treatment approaches targeting negative symptoms in at least two diagnostic groups of patients.Pharmacological treatments include modulators of the monoamergic systems.Antidepressants have been employed in different disorders, but they have only limited effects against negative symptoms without concurrent depression.Stimulants have proven to be effective against negative symptoms in neurological disorders, but clear evidence for efficacy in schizophrenia and affective disorders is lacking.Newer approaches including the use of memantine and anti-inflammatory drugs will be briefly discussed.Psychosocial treatments have rarely targeted negative symptoms as primary outcome.Nevertheless, cognitive behaviour therapy seems to be a valid treatment option for negative symptoms, but will also have to take into account the diagnostic context.Cognitive impairment has been linked to negative symptoms and recent studies suggest a positive effect of cognitive remediation that is not restricted to patients with schizophrenia.Finally, an increasing number of studies shows a beneficial effect of physical exercise on negative symptoms, although these symptoms have rarely been defined as the primary outcome.Future development of transdiagnostic treatment approaches should aim at a better integration of pharmacological and psychosocial treatment approaches.A truly dimensional approach to the treatment of negative symptoms will eventually require transdiagnostic treatment studies, which employ the same treatment protocol across diagnostic categories.Disclosure of interest.-SKreceives royalties for cognitive test and training software from Schuhfried (Austria).

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Core Symposium. (2018). European Psychiatry, 48(S1), S4–S10. https://doi.org/10.1016/j.eurpsy.2017.12.017

MLA 9

“Core Symposium.” European Psychiatry, vol. 48, no. S1, 2018, pp. S4–S10. https://doi.org/10.1016/j.eurpsy.2017.12.017.

Chicago

2018. “Core Symposium.” European Psychiatry 48 (S1): S4–S10. https://doi.org/10.1016/j.eurpsy.2017.12.017.

Harvard

(2018) ‘Core Symposium’, European Psychiatry, 48(S1), pp. S4–S10. doi:10.1016/j.eurpsy.2017.12.017.

IEEE

“Core Symposium,” European Psychiatry, vol. 48, no. S1, pp. S4–S10, 2018, doi: 10.1016/j.eurpsy.2017.12.017.

BibTeX

@article{anon2018core,
  title     = {{Core Symposium}},
  journal   = {European Psychiatry},
  year      = {2018},
  volume    = {48},
  number    = {S1},
  pages     = {S4--S10},
  doi       = {10.1016/j.eurpsy.2017.12.017},
  url       = {https://doi.org/10.1016/j.eurpsy.2017.12.017}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment

  • negative symptoms
  • transdiagnostic treatment
  • dimensional approach
  • neuropsychiatric disorders
  • pharmacotherapy
  • psychosocial interventions
  • cognitive behavioral therapy
  • cognitive remediation

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Core Symposium. (2018). European Psychiatry, 48(S1), S4–S10. https://doi.org/10.1016/j.eurpsy.2017.12.017

How many times has this paper been cited?

0 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at European Psychiatry: sign in and open the PDF from this page.

What is the DOI of this paper?

10.1016/j.eurpsy.2017.12.017, permanently at https://doi.org/10.1016/j.eurpsy.2017.12.017. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.